As of 27 Oct 2026, Parasol Med Tech has raised $2.8M across 1 verified round on record; latest: $2.75 million pre-seed round, announced 26 Oct 2026.
Parasol Med Tech develops an integrated catheter-and-gel system for left atrial appendage closure to improve stroke prevention.
parasolmedtech.comLinkedInChicago, ILMedtech
3 sources · checked 2 times, last 2h ago
Sources agree on the round details. The company release is preferred for the investor name “UChicago Medicine Ventures.”
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-seed pre-seed funding round | $2.8M | 2026-10-26 | not stated | 3 outlets. #20 in Trending |
3 sources · checked 2 times, last 2h ago [ VERIFIED · CORRECTED ] read against 3 sources
Sources agree on the round details. The company release is preferred for the investor name “UChicago Medicine Ventures.” | ||||
Parasol Med Tech is developing an integrated catheter-and-gel system for clinicians to close the left atrial appendage in patients with atrial fibrillation without leaving a permanent metal implant.
Atrial fibrillation can cause clots in the left atrial appendage, raises stroke risk five-fold, and affects nearly 5% of U.S. adults, while existing fixed devices can create fit, leak, clot, and bleeding challenges. The $2.75 million pre-seed round is funding R&D and testing of Parasol’s investigational catheter-and-gel system, a bet that a patient-specific seal can address variable anatomy and move the technology closer to human testing.
Checked against 8 sources yesterday
Also named as backers in company research: UCM Ventures, George Shultz Innovation Fund, UChicago Science Incubator
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Investment | $250,000 | 2026-06-17 | not stated | |